Physician profile
Saied Asfa
NPI 1780609602
$4,854.11
in general payments reported to CMS, 2019-2025
23 companies · $318 in 2025
The $318 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,112 · 2020: $427 · 2021: $1,419 · 2022: $491 · 2023: $729 · 2024: $360 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,406.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,484.27 | 2019-2022 | |
| Merz North America, INC. | $1,191.78 | 2019-2025 | Xeomin |
| Abbvie INC. | $522.98 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Integra Lifesciences Corporation | $359.88 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Musculoskeletal Transplant Foundation INC. | $308.68 | 2019-2020 | |
| Mentor Worldwide LLC | $256.77 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Sientra, INC. | $142.76 | 2020-2022 | |
| Tela Bio, INC. | $111.30 | 2021-2022 | |
| Smith+Nephew, INC. | $104.12 | 2019-2022 | |
| Organogenesis INC. | $73.09 | 2019-2025 | Apligraf, Puraply |
| Kci USA, INC. | $46.49 | 2019-2022 | |
| Medtronic, INC. | $39.08 | 2021-2024 | V-Loc 180 |
| Pacira Pharmaceuticals Incorporated | $34.18 | 2022 | |
| Bioventus LLC | $26.44 | 2022 | |
| Baxter Healthcare | $23.87 | 2023 | Artiss |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $20.71 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Tei Medical INC. | $18.57 | 2019 | |
| Tei Biosciences INC | $17.90 | 2019 | |
| Novo Nordisk INC | $16.84 | 2023 | Wegovy |
| Aroa Biosurgery Incorporated | $15.01 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.80 | 2025 | Libtayo |
| Solventum Corporation | $13.57 | 2024 | Promogran Prisma |
| Tactile Systems Technology INC | $12.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saied Asfa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.